Delta Asset Management’s AstraZeneca AZN Stock Holding History

Delta Asset Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-54	Closed	-$7.21K	–	662
2023 Q4	$7.21K	Buy	54 +4	+8%	+$520	﹤0.01%	483
2023 Q3	$6.77K	Hold	50	–	–	﹤0.01%	490
2023 Q2	$7.16K	Hold	50	–	–	﹤0.01%	492
2023 Q1	$6.94K	Hold	50	–	–	﹤0.01%	470
2022 Q4	$6.78K	Buy	+50	New	+$6.27K	﹤0.01%	481
2022 Q1	–	Sell	-50	Closed	-$6K	–	182
2021 Q4	$6K	Hold	50	–	–	﹤0.01%	517
2021 Q3	$6K	Hold	50	–	–	﹤0.01%	512
2021 Q2	$6K	Hold	50	–	–	﹤0.01%	517
2021 Q1	$5K	Hold	50	–	–	﹤0.01%	504
2020 Q4	$5K	Hold	50	–	–	﹤0.01%	499
2020 Q3	$5K	Hold	50	–	–	﹤0.01%	474
2020 Q2	$5K	Hold	50	–	–	﹤0.01%	484
2020 Q1	$4K	Hold	50	–	–	﹤0.01%	500
2019 Q4	$5K	Hold	50	–	–	﹤0.01%	513
2019 Q3	$4K	Hold	50	–	–	﹤0.01%	520
2019 Q2	$4K	Hold	50	–	–	﹤0.01%	462
2019 Q1	$4K	Hold	50	–	–	﹤0.01%	458
2018 Q4	$4K	Hold	50	–	–	﹤0.01%	524
2018 Q3	$4K	Hold	50	–	–	﹤0.01%	552
2018 Q2	$4K	Hold	50	–	–	﹤0.01%	543
2018 Q1	$3K	Buy	+50	New	+$3.46K	﹤0.01%	567

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Delta Asset Management's AZN Position: Q1 2024 in Review

Delta Asset Management sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 54 shares — an estimated $7.21K sold.

Delta Asset Management first reported a position in AZN in Q1 2018 and held it in 21 quarters. The position peaked at $7.21K in Q4 2023. 1,142 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

Delta Asset Management reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
Delta Asset Management sold 54 AstraZeneca shares in Q1 2024, an estimated $7.21K.
Delta Asset Management first reported a position in AstraZeneca in Q1 2018 and held it in 21 quarters.
Delta Asset Management's AstraZeneca position peaked at $7.21K in Q4 2023.
1,142 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Delta Asset Management's 13F filing for Q1 2024, filed 13 May 2024.